7237129
SARS-CoV-2 Spike RBD LlamabodyTM VHH His-tag Antibody, R&D Systems™
Llama Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Spike RBD
Dilution
Blockade of Receptor-ligand Interaction
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Immunogen
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD, Arg319-Phe541, Accession # YP_009724390.1
Purification Method
Protein A or G purified from cell culture supernatant
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Clone
L009.1.32N
Applications
Blocking Assay
Conjugate
Unconjugated
Host Species
Llama
Target Species
SARS-CoV-2
Gene Accession No.
YP_009724390.1
Primary or Secondary
Primary
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Description
- Spike RBD Monoclonal antibody specifically detects Spike RBD in SARS-CoV-2 samples
- It is validated for Blocking Assay
Compare Similar Items
Show Difference
Antigen: Spike RBD
Dilution: Blockade of Receptor-ligand Interaction
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Immunogen: Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD, Arg319-Phe541, Accession # YP_009724390.1
Purification Method: Protein A or G purified from cell culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Clone: L009.1.32N
Applications: Blocking Assay
Conjugate: Unconjugated
Host Species: Llama
Target Species: SARS-CoV-2
Gene Accession No.: YP_009724390.1
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen:
Spike RBD
Dilution:
Blockade of Receptor-ligand Interaction
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Immunogen:
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD, Arg319-Phe541, Accession # YP_009724390.1
Purification Method:
Protein A or G purified from cell culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Clone:
L009.1.32N
Applications:
Blocking Assay
Conjugate:
Unconjugated
Host Species:
Llama
Target Species:
SARS-CoV-2
Gene Accession No.:
YP_009724390.1
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen: Spike RBD
Dilution: Blockade of Receptor-ligand Interaction
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Immunogen: Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Purification Method: Protein A or G purified from cell culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Clone: L009.2.69H
Applications: Blocking Assay
Conjugate: Unconjugated
Host Species: Llama
Target Species: SARS-CoV-2
Gene Accession No.: YP_009724390.1
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen:
Spike RBD
Dilution:
Blockade of Receptor-ligand Interaction
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Immunogen:
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD as immunogen for bivalent Llama VHH-Human IgG2 Fusion Antibody., Arg319-Phe541, Accession # YP_009724390.1
Purification Method:
Protein A or G purified from cell culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Clone:
L009.2.69H
Applications:
Blocking Assay
Conjugate:
Unconjugated
Host Species:
Llama
Target Species:
SARS-CoV-2
Gene Accession No.:
YP_009724390.1
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen: Spike RBD
Dilution: Blockade of Receptor-ligand Interaction
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Immunogen: Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD protein, Arg319-Phe541, Accession # YP_009724390.1
Purification Method: Protein A or G purified from cell culture supernatant
Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Clone: L009.2.69N
Applications: Blocking Assay
Conjugate: Unconjugated
Host Species: Llama
Target Species: SARS-CoV-2
Gene Accession No.: YP_009724390.1
Primary or Secondary: Primary
Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen:
Spike RBD
Dilution:
Blockade of Receptor-ligand Interaction
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Immunogen:
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD protein, Arg319-Phe541, Accession # YP_009724390.1
Purification Method:
Protein A or G purified from cell culture supernatant
Content And Storage:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Clone:
L009.2.69N
Applications:
Blocking Assay
Conjugate:
Unconjugated
Host Species:
Llama
Target Species:
SARS-CoV-2
Gene Accession No.:
YP_009724390.1
Primary or Secondary:
Primary
Reconstitution:
Reconstitute at 0.5 mg/mL in sterile PBS.
Antigen: __
Dilution: __
Classification: __
Form: __
Regulatory Status: __
Formulation: __
Immunogen: __
Purification Method: __
Content And Storage: __
Clone: __
Applications: __
Conjugate: __
Host Species: __
Target Species: __
Gene Accession No.: __
Primary or Secondary: __
Reconstitution: __
Antigen:
__
Dilution:
__
Classification:
__
Form:
__
Regulatory Status:
__
Formulation:
__
Immunogen:
__
Purification Method:
__
Content And Storage:
__
Clone:
__
Applications:
__
Conjugate:
__
Host Species:
__
Target Species:
__
Gene Accession No.:
__
Primary or Secondary:
__
Reconstitution:
__